Starna Scientific appoints Nathan Hulme as a director

To help guide expansion plans at the spectroscopy specialist

Spectroscopy specialist Starna Scientific has appointed Nathan Hulme as a director to help guide the company’s expansion plans.

Hulme’s main responsibilities will include assisting in setting out a business strategy for the company that will address communications with customers and dealers as well as involving leadership of the sales team.

A graduate from Merton College, Oxford University, Hulme has a degree in Philosophy, Politics & Economics (PPE), specialising in Finance and International Economics.

He has also completed a mini-MBA at Tanaka Business School, Imperial College that featured finance, strategy and marketing components.

You may also like

Analysis

Introducing Shimadzu’s MultiNA II: Redefining precision in life science analysis

Designed with users in mind, the MultiNA II MCE-301 is a fully automated microchip electrophoresis system designed to accelerate and simplify genetic analysis workflows in pharmaceutical and biopharmaceutical laboratories
Analysis

New Trace Metal Certification launched for AnalytiChem’s DigiTUBE digestion tubes

Now with industry-leading certification for both volume and trace metals, DigiTUBE disposable digestion tubes deliver quality, save time and cut costs in sample preparation workflows for ICP analyses
Manufacturing

First aid readiness in analytical laboratories

Preparing for chemical emergencies with specialist equipment and training
Regulatory

Ion chromatography in pharmaceutical analysis: a long road to acceptance

John Welch, Associate Director, Butterworth Laboratories, writes on how ion chromatography evolved into a mature and widely adopted pharmaceutical analysis technique
Regulatory

Implementing compendial methods to minimise testing risk

Understanding feasibility testing and verification to ensure reliable analytical results
Regulatory

Visit Butterworth Laboratories at making pharmaceuticals 2026

Meet the team to discuss analytical testing and development support
Analysis

Conjugation chemistry key to unlocking next-generation oligonucleotide therapies, says Bachem

As demand for oligonucleotide therapeutics accelerates, Bachem's Director of Oligonucleotide Production explains how conjugation chemistry is helping CDMOs overcome delivery challenges
Subscribe now